BXP Submits Redesign of Kendall Square Development
BXP unveiled proposed changes to the next phase of its MXD District in Cambridge’s Kendall Square, including an option for two smaller commercial buildings that reflect “evolving market conditions.”
Boston-Area Lab Vacancies Hit 25 Percent as Industry Retrenches
The lab space vacancy rate hit 25 percent across the region during the first quarter, as companies continued to downsize and list new sublease space.
Biogen Relocating to MIT Development in Cambridge
Biogen Inc. will relocate its headquarters to MIT’s new Kendall Square development after leasing 580,000 square feet in the first new lab building at Kendall Common.
Court Rules Biogen Not to Blame for Subtenants’ Woes
A Suffolk Superior Court judge dismissed a biomanufacturing company’s lawsuit that claimed disruption caused by a Kendall Square development caused it to lose virtually all of its long-term contracts.
Biogen Reportedly Scouts Volpe Move
Biogen is reportedly in negotiations to lease up to 500,000 square feet as the first tenant at MIT’s redevelopment of the Volpe Center property in Cambridge.
BXP, Tenant in Lawsuit Tied to Three-Tower Kendall Project
A contract biomanufacturer says a planned redevelopment by Boston Properties could disrupt its current and future business if the Kendall Square property where it has invested $100 million since 2017 is demolished.
BXP Picks Up Kendall Mid-Rise for $602M
One of Kendall Square’s dominant players just added a new property to its portfolio as troubled life-science firm Biogen exits a major lease nearby.
Biogen Seeks to Sublease Cambridge, Weston Properties
Biogen is offering over 263,000 square feet of office and research space in Cambridge and Weston for sublease in the latest retrenchment of the life science industry’s local footprint.
Boston Harbor Hotel Closing Saturday
The Boston Harbor Hotel will close indefinitely beginning Saturday as the hospitality industry absorbs the initial brunt of the coronavirus’ impact on real estate.
With Emergency Declaration, Mass. Adopts New Virus Strategy
Gov. Charlie Baker declared a state of emergency around the coronavirus outbreak in Massachusetts on Tuesday and outlined new protocols for state employees.
Biotech and Pharma Are Big Business for Massachusetts
More than one-third of all venture capital money invested in biopharmaceutical companies last year went to Massachusetts companies, with the bulk of those dollars headed to companies in Cambridge and nearby, according to a new industry report.
Biogen Leases 80,000 Square Feet In Kendall Square
Biogen has signed a 10-year lease for 80,000 square...
